Showing results (91-100 of 109) with videos related to
Sort By:
Pageof 11
The Journal of Pharmacology and Experimental Therapeutics|January 31, 2006
In vivo characterization of Abeta(40) changes in brain and cerebrospinal fluid using the novel gamma-secretase inhibitor N-[cis-4-[(4-chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl)cyclohexyl]-1,1,1-trifluoromethanesulfonamide (MRK-560) in the ratJonathan D Best, Mark T Jay, Franklin Otu, et al.Bioorganic & Medicinal Chemistry Letters|November 1, 2003
High affinity, bioavailable 3-amino-1,4-benzodiazepine-based gamma-secretase inhibitorsAndrew P Owens, Alan Nadin, Adam C Talbot, et al.Lung Cancer Management|March 5, 2026
Addition of pulsed electric field ablation to SBRT for lung tumors: effect on health-related quality of lifeJeremy P Harris, Christina Boyd, Mengying Shi, et al.Facial Plastic Surgery & Aesthetic Medicine|August 28, 2025
International, Multispecialty Expert Consensus on Nomenclature for Facial ParalysisSamuel L Oyer, Rachel Baptista, Kofi Boahene, et al.Frontiers in Cardiovascular Medicine|November 11, 2021
Stage-Dependent Impact of RIPK1 Inhibition on Atherogenesis: Dual Effects on Inflammation and Foam Cell DynamicsYuze Zhang, Huihui Li, Yonghu Huang, et al.Science Signaling|November 8, 2018
Mammalian pigmentation is regulated by a distinct cAMP-dependent mechanism that controls melanosome pHDalee Zhou, Koji Ota, Charlee Nardin, et al.Journal of Applied Clinical Medical Physics|April 14, 2016
Commissioning and initial experience with the first clinical gantry-mounted proton therapy systemTianyu Zhao, Baozhou Sun, Kevin Grantham, et al.International Journal of Particle Therapy|September 30, 2024
ACR-ARS Practice Parameter for the Performance of Proton Beam TherapySteven J Frank, Indra J Das, Charles B Simone, et al.The Journal of Pharmacology and Experimental Therapeutics|March 4, 2005
Quantitative measurement of changes in amyloid-beta(40) in the rat brain and cerebrospinal fluid following treatment with the gamma-secretase inhibitor LY-411575 [N2-[(2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl]-N1-[(7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl]-L-alaninamide]Jonathan D Best, Mark T Jay, Franklin Otu, et al.International Journal of Radiation Oncology, Biology, Physics|May 19, 2026
Non-invasive Reversible Software-based Electron FLASH Irradiation Configuration of a Linear Accelerator in Clinical UseStavros Melemenidis, Dixin Chen, Cody Jensen, et al.Pageof 11